Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP vs PF Adjuvant Chemotherapy in N2-3 Nasopharyngeal Carcinoma
NCT03321539Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Oct 2017; status: active, not recruiting.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03321539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321539.